Transdermal route is a promising alternative for oral and injectable drug delivery wherein skin is the primary site for drug administration. This drug delivery system offers certain benefits, such as non-invasiveness, controlled & complete drug delivery from the dosage form and improved patient compliance. Transdermal patches, ointments, gel and implants are the popular transdermal drug delivery systems. Over the past few years, transdermal patches have gained significant importance. The transdermal drug delivery market has witnessed vertical growth over the past few decades and this trend is expected to continue during the forecast period. This growth would be driven by the steadily growing number of transdermal drug delivery products in the market resulting from the widespread adoption of these products by consumers. Johnson and Johnson, Acrux, Antares Pharma, Dermatrends Inc., Bayer HealthCare Pharmaceuticals, Novartis, Janssen Pharmaceuticals Inc. and Durect Corporation are some of the key leaders in the global transdermal drug delivery systems market. Recently, NuPathe Inc. received FDA clearance for their transdermal patch, Zeltrix. It is a single use preparation intended for the treatment of migraine pain.
The global transdermal drug delivery systems market is segmented on the basis of application, technology and geography. The application segment is further categorized into CNS, Pain Management, Hormone, Cardiovascular and Others. Transdermal patches for pain management and hormonal drug delivery dominate the market. Vivelle-dot and Climara are estrogen patches currently available in the market, offered by Novartis and Bayer HealthCare Pharmaceuticals, respectively. They are used in the delivery of estradiol for hormone replacement therapy. Based on technology, the global transdermal drug delivery systems market is segmented into Electroporation, Electric current, Lontophoresis, Radio Frequency, Microporation, Thermal, Mechanical arrays and Ultrasound. These technologies form an efficacious drug delivery system by improving the drug distribution pattern across the skin. Geographically, the global transdermal drug delivery systems market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America and Europe dominate the global market due to extensive R&D efforts and presence of numerous approved transdermal products.
This report offers the following benefits in particular:
KEY MARKET SEGMENTS
The global transdermal drug delivery systems market is segmented into three major categories: application, technology and geography.
MARKET BY APPLICATION
MARKET BY TECHNOLOGY
MARKET BY GEOGRAPHY
SIMILAR MARKET STUDIES
Summary Innate Pharma S.A. (Innate Pharma) is a bio-pharmaceutical company that specializes in the areas of immunopharmacology and antibody technology. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclonal antibodies that targets receptors and pathways in controlling ...
September 2016 | $250 | View Details >>
Summary Wilex AG (Wilex) develops diagnostic and therapeutic products for the treatment of various types of cancer. The therapeutic products developed by the company are based on monoclonal antibodies and small molecules. Its small molecule product pipeline comprises Mesupron being studied for the treatment of pancreatic and breast cancer; WX-554, for ...
March 2016 | $250 | View Details >>
The United States Dabigatran Etexilate Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Dabigatran Etexilate industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of ...
April 2017 | $3700 | View Details >>
Agenus, Inc. (AGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential ...
April 2014 | $125 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research